Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia over 6 months: Double-blind randomized trial incorporating experimental pain models
Contributors to the ongoing epidemic of prescription opioid abuse, addiction, and death include opioid tolerance, withdrawal symptoms, and possibly opioid-induced hyperalgesia (OIH). Thirty stable chronic non-malignant pain patients entered a six-month long, randomized, double-blind, dose-response, two-center trial of the potent opioid levorphanol, conducted over a decade ago during an era of permissive opioid prescribing. Eleven were taking no opioids at study entry and eleven were taking between 35-122 morphine equivalents (MEQ).
Source: The Journal of Pain - Category: Materials Science Authors: Michael C. Rowbotham, Mark Wallace Tags: Original Reports Source Type: research
More News: Addiction | Cancer & Oncology | Chronic Pain | Epidemics | Epidemiology | Materials Science | Morphine | Pain | Study